Intensive Care Unit Market
完整報告名稱與涵蓋範圍
Intensive Care Unit Market Research Report by Product Type (Pulse Oximeter, Sphygmomanometer, Beds, Ventilators, Oxygen Concentrators, Resuscitators, Patients Monitors, Infusion Systems, Others), by Application (Cardiovascular Disease, Oncology, Respiratory, Neurology, Others), by End User (Hospital, Specialty Clinics), and by Region (North America, Europe , Asia-Pacific, South America, MEA) Forecast till 2035
報告摘要
The Global Intensive Care Unit (ICU) Market is projected to reach USD 12,689.8 million by 2035, expanding at a CAGR of 4.7% from 2025 to 2035. This steady growth reflects rising demand for advanced critical care infrastructure and services worldwide.
Escalating Burden of Non-Communicable Diseases (NCDs)
The increasing occurrence of chronic diseases such as cardiovascular diseases, cancer, respiratory disorders, and diabetes, that account for almost three-quarters of deaths worldwide, is a major factor behind the continued ICU admissions for acute complications. This trend is making the patients even more dependent on intensive care requiring an advanced infrastructure for intensive care around the world.
Segment-Wise Snapshot of ICU Market
By Product Type:
• Pulse Oximeter – Continuous oxygen saturation monitoring in ICU
• Sphygmomanometer – Accurate blood pressure measurement in critical care
• Beds – Adjustable ICU beds for patient support and care
• Ventilators – Life-support systems for severe respiratory failure
• Oxygen Concentrators – Reliable oxygen supply for critical patients
• Resuscitators – Emergency devices for immediate patient revival
• Patient Monitors – Real-time tracking of vital health parameters
• Infusion Systems – Controlled delivery of fluids and medications
• Others – Auxiliary devices supporting ICU treatment processes
By Application:
• Cardiovascular Disease – Intensive care for cardiac emergencies
• Oncology – Critical support for cancer-related complications
• Respiratory – Management of severe respiratory disorders
• Neurology – ICU care for stroke and brain injuries
• Others – Treatment of diverse critical health conditions
By End User:
• Hospital – Primary centers for advanced ICU treatment
• Specialty Clinics – Focused care for specific critical conditions
Global ICU Market Regional Snapshot
Advanced ICU infrastructure is available in North America and Europe that are however facing capacity issues and regional disparities. Rapidly growing expansion of ICU infrastructure has been witnessed in Asia Pacific whereas South America and MEA continue to suffer from the issues of uneven access and infrastructure.
Strategic Partnerships Enhancing Monitoring Capabilities
Koninklijke Philips N.V., through its new strategic collaborations aimed at advancing patient-monitoring technologies and expanding clinical capabilities, is continuously enhancing its ICU portfolio. The new and additional multi-year Medtronic collaboration was geared at integrating advanced sensor solutions into Philips' systems while reducing procurement procedures and improving access to critical monitoring tools across hospitals.
Digital Transformation Driving ICU Efficiency
Hospitals are now able to cover ICU more effectively, optimize resource usage, and cope with geographically dispersed patients through tele-critical care solutions. By improving operational scalability and care delivery, this digital transformation is offering a strong strategic advantage.
Key Report Attributes
• Market Size 2035: USD 12,689.8 Million
• CAGR (2025-2035): 4.7%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Product Type: Pulse Oximeter - 6.8%, Sphygmomanometer - 9.3%.
• By Application: Cardiovascular Disease - 3.5%, Oncology - 5.5%
• By End User: Hospital - 4.4%, Specialty Clinics - 5.9%.
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............ 19
2 MARKET INTRODUCTION ......... 21
2.1 DEFINITION ......... 21
2.2 SCOPE OF THE STUDY ....... 21
2.3 RESEARCH OBJECTIVE .............. 21
2.4 MARKET STRUCTURE ....... 22
3 RESEARCH METHODOLOGY ............ 23
3.1 OVERVIEW ........... 23
3.2 DATA FLOW ......... 25
3.2.1 DATA MINING PROCESS ......... 25
3.3 PURCHASED DATABASE: ........... 26
3.4 SECONDARY SOURCES: .............. 27
3.4.1 SECONDARY RESEARCH DATA FLOW: ............ 28
3.5 PRIMARY RESEARCH: ........ 29
3.5.1 PRIMARY RESEARCH DATA FLOW: ........... 30
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ....... 31
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE .......... 31
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......... 32
3.6.1 CONSUMPTION & NET TRADE APPROACH ............. 32
3.6.2 REVENUE ANALYSIS APPROACH ....... 32
3.7 DATA FORECASTING.......... 33
3.7.1 DATA FORECASTING TECHNIQUE ....... 33
3.8 DATA MODELING ........ 34
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........... 34
3.8.2 DATA MODELING: ........ 35
3.9 TEAMS AND ANALYST CONTRIBUTION ........ 37
4 MARKET DYNAMICS ........ 39
4.1 INTRODUCTION ........... 39
4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS ............ 40
4.3 GROWTH PARAMETERS MAPPED - DRIVERS ....... 40
4.3.1 RAPID POPULATION AGEING AND GROWTH OF HIGH-RISK COHORTS ....... 40
4.3.2 RISING BURDEN OF NCDS AND ACUTE COMPLICATIONS ............ 41
4.3.3 EXPANSION OF SURGICAL, EMERGENCY, AND TRAUMA CARE REQUIRING ICU SUPPORT ......... 42
4.3.4 RISING HEALTH EXPENDITURE AND POLICY FOCUS ON EMERGENCY & CRITICAL CARE ............ 43
4.3.5 HEALTH SECURITY IMPERATIVES AND PANDEMIC PREPAREDNESS POST COVID-19 ....... 43
4.4 GROWTH INHIBITORS MAPPED - RESTRAINTS ............ 45
4.4.1 CRITICAL-CARE WORKFORCE SHORTAGES AND BURNOUT ...... 45
4.4.2 HIGH-COST INTENSITY OF ICU CARE AND BUDGET PRESSURES ........... 46
4.4.3 STRUCTURAL INFRASTRUCTURE AND ACCESS GAPS, ESPECIALLY IN LMICS ......... 46
4.5 MARKET OPPORTUNITIES MAPPED ....... 48
4.5.1 SCALING TELE-ICU, INTEROPERABLE MONITORING, AND AI-ENABLED DECISION SUPPORT ....... 48
4.5.2 INFECTION-PREVENTION AND AMR-FOCUSED ICU SOLUTIONS...... 48
4.5.3 AFFORDABLE CRITICAL-CARE MODELS FOR LMICS BACKED BY GLOBAL FINANCING ....... 49
4.6 IMPACT ANALYSIS OF COVID – 19 ........... 50
4.6.1 IMPACT ON OVERALL F&B MARKET ............. 51
4.6.2 IMPACT ON GLOBAL INTENSIVE CARE UNIT (ICU) MARKET .......... 53
4.6.3 IMPACT ON SUPPLY CHAIN OF INTENSIVE CARE UNIT (ICU) MARKET .............. 54
4.6.4 IMPACT ON MARKET DEMAND OF INTENSIVE CARE UNIT (ICU) MARKET .......... 56
4.6.5 IMPACT ON PRICING OF INTENSIVE CARE UNIT (ICU) MARKET .............. 57
5 MARKET FACTOR ANALYSIS ............ 59
5.1 REGULATORY ENVIRONMENT & COMPLIANCE ............ 59
5.2 TECHNOLOGICAL TRENDS & INNOVATION ............ 60
5.3 MARKET ENTRY & EXIT BARRIERS ........ 63
5.4 PARTNERSHIPS & COLLABORATIONS ............. 64
5.5 CONSUMER & HEALTHCARE PROVIDER PREFERENCES .............. 67
5.6 PESTLE ANALYSIS .............. 69
5.6.1 POLITICAL FACTORS ...... 69
5.6.2 ECONOMIC FACTORS ............. 69
5.6.3 SOCIAL FACTORS ......... 69
5.6.4 TECHNOLOGICAL FACTORS ...... 70
5.6.5 LEGAL FACTORS .......... 70
5.6.6 ENVIRONMENTAL FACTORS ...... 70
5.7 PORTER’S FIVE FORCES MODEL ...... 71
5.7.1 BARGAINING POWER OF SUPPLIERS ............. 71
5.7.2 BARGAINING POWER OF BUYERS ....... 72
5.7.3 THREAT OF NEW ENTRANTS .............. 72
5.7.4 THREAT OF SUBSTITUTES ........ 73
5.7.5 INTENSITY OF RIVALRY ............ 73
5.8 INVESTMENT & FUNDING SCENARIOS ........... 73
6 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE .......... 77
6.1 INTRODUCTION ........... 77
6.2 PULSE OXIMETER ...... 79
6.3 SPHYGMOMANOMETER ............ 81
6.4 BEDS .............. 82
6.5 VENTILATORS ............. 84
6.6 OXYGEN CONCENTRATORS .............. 86
6.7 RESUSCITATORS ........ 88
6.8 PATIENTS MONITORS ....... 90
6.9 INFUSION SYSTEMS ........... 92
6.10 OTHERS ........ 94
7 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION .............. 97
7.1 INTRODUCTION ........... 97
7.2 CARDIOVASCULAR DISEASE ............. 99
7.3 ONCOLOGY ........... 101
7.4 RESPIRATORY ............. 103
7.5 NEUROLOGY ........ 105
7.6 OTHERS ........ 106
8 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER .......... 109
8.1 INTRODUCTION ........... 109
8.2 HOSPITAL ............. 110
8.3 SPECIALTY CLINICS ........... 113
9 GLOBAL INTENSIVE CARE UNIT MARKET, BY REGION .............. 115
9.1 OVERVIEW ........... 115
9.2 NORTH AMERICA ....... 116
9.2.1 U.S........ 120
9.2.2 CANADA .......... 122
9.3 EUROPE ........ 123
9.3.1 GERMANY ........ 127
9.3.2 UK ........ 128
9.3.3 FRANCE ........... 130
9.3.4 RUSSIA ............ 131
9.3.5 ITALY ...... 132
9.3.6 SPAIN ............. 134
9.3.7 REST OF EUROPE ......... 135
9.4 ASIA-PACIFIC ...... 137
9.4.1 CHINA ............. 141
9.4.2 INDIA .............. 142
9.4.3 JAPAN ............ 144
9.4.4 SOUTH KOREA ............ 145
9.4.5 MALAYSIA ........ 146
9.4.6 THAILAND ......... 148
9.4.7 INDONESIA ....... 149
9.4.8 REST OF ASIA PACIFIC .......... 150
9.5 SOUTH AMERICA ....... 152
9.5.1 BRAZIL ............. 156
9.5.2 MEXICO ........... 157
9.5.3 ARGENTINA ....... 159
9.5.4 REST OF SOUTH AMERICA ...... 160
9.6 MIDDLE EAST & AFRICA ............ 162
9.6.1 GCC COUNTRIES .......... 166
9.6.2 SOUTH AFRICA ............. 168
9.6.3 REST OF MEA ............ 169
10 COMPETITIVE LANDSCAPE .............. 172
10.1 INTRODUCTION ........... 172
10.2 COMPETITION DASHBOARD .............. 173
10.2.1 PRODUCT PORTFOLIO ...... 174
10.2.2 REGIONAL PRESENCE ....... 174
10.2.3 STRATEGIC ALLIANCES ............. 174
10.2.4 INDUSTRY EXPERIENCES ........... 174
10.3 MARKET SHARE ANALYSIS, 2024 ........... 174
10.4 WHO ARE THE MAJOR DISRUPTORS & INNOVATORS ......... 175
10.5 WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS ........... 176
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ........... 177
10.6.1 PRODUCT LAUNCH ........... 177
10.6.2 AGREEMENT AND PARTNERSHIP ........ 177
10.6.3 OTHER ............. 178
11 COMPANY PROFILES ...... 179
11.1 KONINKLIJKE PHILIPS N.V. .............. 179
11.1.1 COMPANY OVERVIEW ....... 179
11.1.2 FINANCIAL OVERVIEW ...... 180
11.1.3 PRODUCTS OFFERED......... 181
11.1.4 KEY DEVELOPMENTS ........ 181
11.1.5 SWOT ANALYSIS .............. 182
11.1.6 KEY STRATEGY ............ 182
11.2 MEDTRONIC ........ 183
11.2.1 COMPANY OVERVIEW ....... 183
11.2.2 FINANCIAL OVERVIEW ...... 184
11.2.3 PRODUCTS OFFERED......... 184
11.2.4 KEY DEVELOPMENTS ........ 185
11.2.5 SWOT ANALYSIS .............. 185
11.2.6 KEY STRATEGY ............ 186
11.3 HAMILTON MEDICAL AG ........... 187
11.3.1 COMPANY OVERVIEW ....... 187
11.3.2 PRODUCTS OFFERED......... 188
11.3.3 SWOT ANALYSIS .............. 188
11.3.4 KEY STRATEGY ............ 188
11.4 GETINGE AB ........ 190
11.4.1 COMPANY OVERVIEW ....... 190
11.4.2 FINANCIAL OVERVIEW ...... 191
11.4.3 PRODUCTS OFFERED......... 191
11.4.4 KEY DEVELOPMENTS ........ 192
11.4.5 SWOT ANALYSIS .............. 192
11.4.6 KEY STRATEGY ............ 193
11.5 GE HEALTHCARE ....... 194
11.5.1 COMPANY OVERVIEW ....... 194
11.5.2 FINANCIAL OVERVIEW ...... 196
11.5.3 PRODUCTS OFFERED......... 196
11.5.4 SWOT ANALYSIS .............. 197
11.5.5 KEY STRATEGY ............ 197
11.6 STRYKER CORPORATION .......... 198
11.6.1 COMPANY OVERVIEW ....... 198
11.6.2 FINANCIAL OVERVIEW ...... 199
11.6.3 PRODUCTS OFFERED......... 199
11.6.4 SWOT ANALYSIS .............. 201
11.6.5 KEY STRATEGY ............ 201
11.7 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD. ............ 202
11.7.1 COMPANY OVERVIEW ....... 202
11.7.2 PRODUCTS OFFERED......... 203
11.7.3 SWOT ANALYSIS .............. 204
11.7.4 KEY STRATEGY ............ 204
11.8 VYAIRE MEDICAL, INC. .............. 205
11.8.1 COMPANY OVERVIEW ....... 205
11.8.2 PRODUCTS OFFERED......... 206
11.8.3 SWOT ANALYSIS .............. 206
11.8.4 KEY STRATEGY ............ 206
11.9 ICU MEDICAL, INC. .............. 207
11.9.1 COMPANY OVERVIEW ....... 207
11.9.2 PRODUCTS OFFERED......... 208
11.9.3 KEY DEVELOPMENTS ........ 208
11.9.4 SWOT ANALYSIS .............. 209
11.9.5 KEY STRATEGY ............ 209
11.10 BAXTER INTERNATIONAL ....... 210
11.10.1 COMPANY OVERVIEW ....... 210
11.10.2 FINANCIAL OVERVIEW ...... 211
11.10.3 PRODUCTS OFFERED......... 212
11.10.4 KEY DEVELOPMENTS ........ 212
11.10.5 SWOT ANALYSIS .............. 212
11.10.6 KEY STRATEGY ............ 213
12 DATA CITATIONS ............. 214
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 35
TABLE 2 KEY PARTNERSHIP TYPES IN THE ICU MARKET 65
TABLE 3 SELECTED GLOBAL ICU-RELEVANT COLLABORATIONS 66
TABLE 4 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION) 78
TABLE 5 GLOBAL INTENSIVE CARE UNIT MARKET, BY PULSE OXIMETER, 2024 & 2035 (USD MILLION) 80
TABLE 6 GLOBAL INTENSIVE CARE UNIT MARKET, BY SPHYGMOMANOMETER, 2024 & 2035 (USD MILLION) 82
TABLE 7 GLOBAL INTENSIVE CARE UNIT MARKET, BY BEDS, 2024 & 2035 (USD MILLION) 84
TABLE 8 GLOBAL INTENSIVE CARE UNIT MARKET, BY VENTILATORS, 2024 & 2035 (USD MILLION) 86
TABLE 9 GLOBAL INTENSIVE CARE UNIT MARKET, BY OXYGEN CONCENTRATORS, 2024 & 2035 (USD MILLION) 88
TABLE 10 GLOBAL INTENSIVE CARE UNIT MARKET, BY RESUSCITATORS, 2024 & 2035 (USD MILLION) 90
TABLE 11 GLOBAL INTENSIVE CARE UNIT MARKET, BY PATIENT MONITORS, 2024 & 2035 (USD MILLION) 92
TABLE 12 GLOBAL INTENSIVE CARE UNIT MARKET, BY INFUSION SYSTEMS, 2024 & 2035 (USD MILLION) 94
TABLE 13 GLOBAL INTENSIVE CARE UNIT MARKET, BY OTHERS, 2024 & 2035 (USD MILLION) 96
TABLE 14 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 98
TABLE 15 GLOBAL INTENSIVE CARE UNIT MARKET, BY CARDIOVASCULAR DISEASE, 2024 & 2035 (USD MILLION) 100
TABLE 16 GLOBAL INTENSIVE CARE UNIT MARKET, BY ONCOLOGY, 2024 & 2035 (USD MILLION) 103
TABLE 17 GLOBAL INTENSIVE CARE UNIT MARKET, BY RESPIRATORY, 2024 & 2035 (USD MILLION) 104
TABLE 18 GLOBAL INTENSIVE CARE UNIT MARKET, BY NEUROLOGY, 2024 & 2035 (USD MILLION) 106
TABLE 19 GLOBAL INTENSIVE CARE UNIT MARKET, BY OTHERS, 2024 & 2035 (USD MILLION) 107
TABLE 20 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, 2024 & 2035 (USD MILLION) 110
TABLE 21 GLOBAL INTENSIVE CARE UNIT MARKET, BY HOSPITAL, 2024 & 2035 (USD MILLION) 112
TABLE 22 GLOBAL INTENSIVE CARE UNIT MARKET, BY SPECIALTY CLINICS, 2024 & 2035 (USD MILLION) 114
TABLE 23 GLOBAL INTENSIVE CARE UNITS MARKET, BY REGION, 2019-2035 (USD MILLION) 116
TABLE 24 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 118
TABLE 25 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119
TABLE 26 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 120
TABLE 27 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 120
TABLE 28 U.S. INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 120
TABLE 29 U.S. INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 121
TABLE 30 U.S. INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 121
TABLE 31 CANADA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 122
TABLE 32 CANADA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 122
TABLE 33 CANADA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 123
TABLE 34 EUROPE INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 125
TABLE 35 EUROPE: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 126
TABLE 36 EUROPE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 126
TABLE 37 EUROPE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 127
TABLE 38 GERMANY INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 127
TABLE 39 GERMANY INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 128
TABLE 40 GERMANY INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 128
TABLE 41 UK INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 128
TABLE 42 UK INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 129
TABLE 43 UK INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 129
TABLE 44 FRANCE INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 130
TABLE 45 FRANCE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 130
TABLE 46 FRANCE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 131
TABLE 47 RUSSIA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 131
TABLE 48 RUSSIA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 132
TABLE 49 RUSSIA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 132
TABLE 50 ITALY INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 132
TABLE 51 ITALY INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 133
TABLE 52 ITALY INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 133
TABLE 53 SPAIN INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 134
TABLE 54 SPAIN INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 134
TABLE 55 SPAIN INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 135
TABLE 56 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 135
TABLE 57 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 136
TABLE 58 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 136
TABLE 59 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 139
TABLE 60 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 140
TABLE 61 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 140
TABLE 62 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 141
TABLE 63 CHINA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 141
TABLE 64 CHINA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 142
TABLE 65 CHINA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 142
TABLE 66 INDIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 142
TABLE 67 INDIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 143
TABLE 68 INDIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 143
TABLE 69 JAPAN: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 144
TABLE 70 JAPAN: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 144
TABLE 71 JAPAN: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 144
TABLE 72 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 145
TABLE 73 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 146
TABLE 74 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 146
TABLE 75 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 146
TABLE 76 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 147
TABLE 77 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 147
TABLE 78 THAILAND: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 148
TABLE 79 THAILAND: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 148
TABLE 80 THAILAND: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 148
TABLE 81 INDONESIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 149
TABLE 82 INDONESIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 150
TABLE 83 INDONESIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 150
TABLE 84 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 150
TABLE 85 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 151
TABLE 86 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 151
TABLE 87 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 154
TABLE 88 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 154
TABLE 89 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 155
TABLE 90 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 155
TABLE 91 BRAZIL: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 156
TABLE 92 BRAZIL: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 156
TABLE 93 BRAZIL: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 157
TABLE 94 MEXICO: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 157
TABLE 95 MEXICO: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 158
TABLE 96 MEXICO: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 158
TABLE 97 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 159
TABLE 98 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 159
TABLE 99 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 159
TABLE 100 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 160
TABLE 101 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 161
TABLE 102 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 161
TABLE 103 MIDDLE EAST & AFRICA: INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 164
TABLE 104 MEA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 165
TABLE 105 MEA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 165
TABLE 106 MEA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 166
TABLE 107 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 166
TABLE 108 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 167
TABLE 109 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 167
TABLE 110 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 168
TABLE 111 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 168
TABLE 112 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 169
TABLE 113 REST OF MEA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 169
TABLE 114 REST OF MEA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 170
TABLE 115 REST OF MEA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 170
TABLE 116 PRODUCT LAUNCH 177
TABLE 117 AGREEMENT AND PARTNERSHIP 177
TABLE 118 OTHER 178
TABLE 119 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 181
TABLE 120 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENT 181
TABLE 121 MEDTRONIC: PRODUCTS OFFERED 184
TABLE 122 MEDTRONIC: KEY DEVELOPMENT 185
TABLE 123 HAMILTON MEDICAL AG: PRODUCTS OFFERED 188
TABLE 124 GETINGE AB: PRODUCTS OFFERED 191
TABLE 125 GETINGE AB: KEY DEVELOPMENT 192
TABLE 126 GE HEALTHCARE: PRODUCTS OFFERED 196
TABLE 127 STRYKER CORPORATION: PRODUCTS OFFERED 199
TABLE 128 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 203
TABLE 129 VYAIRE MEDICAL, INC.: PRODUCTS OFFERED 206
TABLE 130 ICU MEDICAL, INC.: PRODUCTS OFFERED
TABLE 131 ICU MEDICAL, INC.: KEY DEVELOPMENTS
TABLE 132 BAXTER INTERNATIONAL: PRODUCTS OFFERED
TABLE 133 BAXTER INTERNATIONAL: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 GLOBAL INTENSIVE CARE UNIT MARKET: STRUCTURE 22
FIGURE 2 GLOBAL INTENSIVE CARE UNIT MARKET: MARKET GROWTH FACTOR ANALYSIS (2025-2035) 39
FIGURE 3 DRIVER IMPACT ANALYSIS (2025-2035) 44
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2025-2035) 47
FIGURE 5 PORTER’S FIVE FORCES MODEL: GLOBAL INTENSIVE CARE UNIT MARKET 71
FIGURE 6 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, SEGMENT ATTRACTIVENESS ANALYSIS 77
FIGURE 7 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION) 78
FIGURE 8 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 (% SHARE) 79
FIGURE 9 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS 97
FIGURE 10 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 98
FIGURE 11 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 (% SHARE) 99
FIGURE 12 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS 109
FIGURE 13 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 109
FIGURE 14 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, 2024 (% SHARE) 110
FIGURE 15 GLOBAL MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 115
FIGURE 16 GLOBAL INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2024 (% SHARE) 116
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 117
FIGURE 18 NORTH AMERICA MARKET: SWOT ANALYSIS 118
FIGURE 19 NORTH AMERICA INTENSIVE CARE UNITS MARKET SHARE (%), BY COUNTRY, 2024 119
FIGURE 20 EUROPE MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 124
FIGURE 21 EUROPE MARKET: SWOT ANALYSIS 124
FIGURE 22 EUROPE INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 125
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 138
FIGURE 24 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 138
FIGURE 25 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 (%) 139
FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 153
FIGURE 27 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 153
FIGURE 28 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 (%) 154
FIGURE 1 MIDDLE EAST & AFRICA MARKET: SWOT ANALYSIS 163
FIGURE 2 MIDDLE EAST & AFRICA: INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 163
FIGURE 3 MIDDLE EAST & AFRICA: BIOSURGERY MARKET SHARE (%), BY COUNTRY, 2024 164
FIGURE 4 COMPETITOR DASHBOARD: GLOBAL UNIT DOSE PACKAGING MARKET 173
FIGURE 5 GLOBAL UNIT DOSE PACKAGING MARKET: COMPETITIVE ANALYSIS, 2024 174
FIGURE 6 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 182
FIGURE 7 MEDTRONIC: SWOT ANALYSIS 185
FIGURE 8 HAMILTON MEDICAL AG: SWOT ANALYSIS 188
FIGURE 9 GETINGE AB: SWOT ANALYSIS 192
FIGURE 10 GE HEALTHCARE: SWOT ANALYSIS 197
FIGURE 11 STRYKER CORPORATION: SWOT ANALYSIS 201
FIGURE 12 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD.: SWOT ANALYSIS 204
FIGURE 13 VYAIRE MEDICAL, INC.: SWOT ANALYSIS 206
FIGURE 14 ICU MEDICAL, INC.: SWOT ANALYSIS
FIGURE 15 BAXTER INTERNATIONAL: SWOT ANALYSIS
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們